Entity > Corporation > US > New York City New York > Electrocore
About electroCore
ElectroCore is a medical technology company that develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
Foundation: In 2005, ElectroCore was founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments with which they were dissatisfied. Because various modalities of neuromodulation had previously been shown to be effective and safe, the company recognized and seized the opportunity to be a leader in this new area of medicine.
Specialisation: ElectroCore specializes in Neuromodulation, Vagal Nerve Stimulation (VNS), Neuroscience, and Bioelectronic Medicine.
ElectroCore’s mission ElectroCore’s mission is simple—help patients across the globe who suffer from pain and chronic conditions. The company is doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.
Industry: Health > Health Conditions > Pain Management
More information about electroCore
| Company Attribute | Value |
| Address | StreetAddress: 200 Forge Way Ste 205, AddressLocality: Rockaway, AddressRegion: New Jersey, PostalCode: 7866, AddressCountry: United States |
| Founding Date | 2005 |
| Name | electroCore |
| Number Of Employees | 52 |
| Revenue | $6,146,000 USD |
| Ticker Symbol | NASDAQ: ECOR |
| Url | electrocore |
| Wikipedia | wikipedia |
| Wikidata | wikidata |
electroCore
New York City, US
21 Apr 2024
electroCore
electroCore (Company)
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger.
-
Headquarters : Rockaway, NJ
-
Founded : 2005
-
Ipo price : $15.00 per share fiercebiotech.com